Skip to main content
Clinical Trials/CTRI/2023/09/057265
CTRI/2023/09/057265
Not yet recruiting
Phase 3

An Open Single-arm, Single-centric Clinical Trial on the therapeutic effectiveness of Varmam Therapy in the management of Otrai Thalai Vali (Migraine) - A pilot study - NI

ational Institute of Siddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G439- Migraine, unspecified
Sponsor
ational Institute of Siddha
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • History of five attacks lasting for 4\-72 hours in the past 3 months
  • Patients having the symptoms of unilateral headache with pulsating quality, pain with mild to moderate intensity and aggravated by routine physical activity
  • Patients must have any one of the following symptoms,
  • Often accompanied by nausea (and/or vomiting)
  • Photophobia
  • Phonophobia
  • Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa
  • Patient who has Headache Impact Test total score 36\-59 and Migraine Disability Assessment Test score 6\-20

Exclusion Criteria

  • K/C/O Cardiovascular disease.
  • K/C/O Trigeminal neuralgia
  • K/C/O Trauma
  • Patients with uncontrolled diabetes mellitus
  • Patients with uncontrolled hypertension
  • K/C/O Psychiatric diseases
  • K/C/O of Seizures
  • K/C/O Eye disease and uncorrected refractive errors
  • K/C/O cervical spondylosis

Outcomes

Primary Outcomes

Not specified

Similar Trials